Cyclacel Pharmaceuticals Inc expected to post a loss of $1.43 a share - Earnings Preview

Bio Green Med Solution

12/08/2024 23:09

* Cyclacel Pharmaceuticals Inc  CYCC.OQ   CYCC.O  is
expected
to show a fall in quarterly revenue when it reports  results on
August 14 for the period ending June 30 2024
    * The Berkeley Heights New Jersey-based  company is expected
to
report a 92.0% decrease in revenue to $30 thousand from $373
thousand a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Cyclacel Pharmaceuticals
Inc
is for a loss of $1.43 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cyclacel
Pharmaceuticals Inc is $11.00​, above​ its last closing price
of $1.37. ​​​

This summary was machine generated August 12 at 22:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)